Measurement of glycated hemoglobin (HbA1c) has been the traditional method for
assessing glycemic control. However, it does not reflect intra-and interday glycemic …

Background Closed-loop artificial pancreas systems have been in development for several
years, including assessment in numerous varied outpatient clinical trials. We aimed to …

Background Open-source automated insulin delivery (AID) systems are used by many
patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source …

Background The achievement of glycaemic control remains challenging for patients with
type 1 diabetes. We assessed the effectiveness of day-and-night hybrid closed-loop insulin …

Continuous glucose monitoring (CGM) provides information unattainable by intermittent
capillary blood glucose, including instantaneous real-time display of glucose level and rate …

By providing blood glucose (BG) concentration measurements in an almost continuous-time
fashion for several consecutive days, wearable minimally-invasive continuous glucose …

Objective To evaluate the efficacy and safety of artificial pancreas treatment in non-pregnant
outpatients with type 1 diabetes. Design Systematic review and meta-analysis of …

By providing blood glucose (BG) concentration measurements in an almost continuous-time
fashion for several consecutive days, wearable minimally-invasive continuous glucose …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Background: A new version of the UVA/Padova Type 1 Diabetes (T1D) Simulator is
presented which provides a more realistic testing scenario. The upgrades to the previous …